Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014

被引:0
|
作者
Arpan Patel
Suna Yapali
Anna S. F. Lok
机构
[1] University of Michigan,Division of Gastroenterology and Hepatology
[2] University of Michigan Health System,Division of Gastroenterology and Hepatology
来源
Hepatology International | 2016年 / 10卷
关键词
Hepatitis B virus; Hepatitis; Liver failure; Chemotherapy; Antiviral therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:139 / 146
页数:7
相关论文
共 50 条
  • [21] Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
    Seto, Wai-Kay
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (06) : 825 - 830
  • [22] Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
    Wai-Kay Seto
    World Journal of Hepatology, 2015, (06) : 825 - 830
  • [23] Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection
    Inoue, Tomoko
    Fuke, Hiroyuki
    Yamamoto, Norihiko
    Ito, Keiichi
    Yoneda, Kentaro
    Yutaka
    Yamanaka
    Shiraki, Katsuya
    HEPATO-GASTROENTEROLOGY, 2007, 54 (75) : 889 - 891
  • [24] A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy
    Harigai, Masayoshi
    Mochida, Satoshi
    Mimura, Toshihide
    Koike, Takao
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 1 - 7
  • [25] Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy
    Yu, Hsien-Chung
    Tseng, Jui-Cheng
    Lu, Ling-Ying
    Hu, Jwi-Chieh
    Chen, Yan-Hua
    Hsu, Chiao-Lin
    Wu, Pin-Chieh
    Mar, Guang-Yuan
    Lin, Kung-Hung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) : 107 - 113
  • [26] Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases
    Kato, Masaru
    Atsumi, Tatsuya
    Kurita, Takashi
    Odani, Toshio
    Fujieda, Yuichiro
    Otomo, Kotaro
    Horita, Tetsuya
    Yasuda, Shinsuke
    Koike, Takao
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (10) : 2209 - 2214
  • [27] Prophylaxis and therapy of reactivation of hepatitis B in immunosuppressed patients
    von Wagner, M.
    Zeuzem, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (06) : 255 - 258
  • [28] Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
    Lubel, John S.
    Angus, Peter W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 864 - 871
  • [29] Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy
    Gonzalez, Stevan A.
    Perrillo, Robert P.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 : S306 - S313
  • [30] Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
    Chun-Jen Liu
    Pei-Jer Chen
    Ding-Shinn Chen
    Jia-Horng Kao
    Hepatology International, 2013, 7 : 316 - 326